Lonza expands ADC capacity; FDA offers track and trace guidance; Pfizer recalls antifungal treatment;

> Contract manufacturer Lonza has expanded its antibody drug conjugate (ADC) clinical manufacturing facility in Visp, Switzerland. Release

> The FDA has published guidance for track and trace requirements. Guidance (PDF)

> India's Emcure has withdrawn from the market a public offering intended to raise money for manufacturing expansion. Story

> Indian state drug regulators in Haryana are now offering an online process for obtaining manufacturing licenses and providing inspectors with laptops so they can check them. Story

> A ban by authorities in Maharashtra, India, against shipping drugs through the mail is being opposed by industry groups there, which say the government is caving to pressure from the U.S. Story

> Pfizer ($PFE) is recalling 4,155 bottles of Greenstone brand orange-flavored fluconazole antifungal drug made in India because of problems with the tamper resistant ring on some bottles. Notice

> Hospira ($HSP) is recalling 85,680 vials of Marcaine because of particulate seen in some. Notice

And Finally... Europe is under growing pressure to pass laws to counter the effects of pharmaceuticals on the environment. Story